Skip to Content
Merck

HCCBP1MAG-58K

MILLIPLEX® Human Circulating Cancer Biomarker Panel

Configurable Human Circulating Cancer Biomarker 25-Plex Panel 1

Synonym(s):

human cancer biomarker immunoassay panel, luminex human circulating cancer biomarkers multiplex assay, millipore human circulating cancer biomarkers multiplex kit, Luminex human circulating cancer biomarkers multiplex assay, Millipore human circulating cancer biomarkers multiplex kit

Sign In to View Organizational & Contract Pricing.

About This Item

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

MILLIPLEX® Human Circulating Cancer Biomarker Panel, Configurable Human Circulating Cancer Biomarker 25-Plex Panel 1

species reactivity

human

manufacturer/tradename

Milliplex®

Quality Level

packaging

1 ea of

assay range

accuracy: 35-108%
standard curve range: 0.09-67 mU/mL
(β-HCG)

standard curve range: 0.7-500 pg/mL
(IL-6)

standard curve range: 1.3-1000 pg/mL
(IL-8, TNFα)

standard curve range: 2.7-2000 pg/mL
(TRAIL, TGF-α)

standard curve range: 6.9-5000 pg/mL
(SCF)

technique(s)

multiplexing: suitable

input

serum plasma (Cell culture, cell culture supernatants)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

Biochem/physiol Actions

Cross Reactivty
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

Preparation Note

Recommended storage for kit components is 2 - 8°C.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 25 analytes in human serum, plasma, and cell culture supernatants.

Analytes included: α-Fetoprotein (AFP), CA125, CA15-3, CA19-9, CEA, CYFRA21-1, sFas (TNFRSF6), sFasL, FGF-2 (FGF-basic), β-HCG (HCGβ), HE4, HGF, IL-6, IL-8 (CXCL8), Leptin, MIF, Osteopontin (OPN), Prolactin, PSA (free)*, PSA (total)*, SCF, TGFα, TNFα, TRAIL (TNFSF10), VEGF

Note: Total PSA and Free PSA cannot be plexed together.Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Disclaimer

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Features and Benefits

  • Extensive 25-Plex Analyte Panel: This kit allows for the simultaneous quantification of 25 specific cancer biomarkers, including α-Fetoprotein (AFP), CA125, CA15-3, CA19-9, CEA, and many others, enabling comprehensive cancer analysis.
  • Flexible Sample Types: Suitable for human serum, plasma, and tissue/cell culture supernatants or lysates, making it versatile for various research applications.
  • Comprehensive Insights into Tumor Biology: By measuring multiple circulating cancer biomarkers simultaneously, researchers can gain deeper insights into tumor dynamics, host response, and the tumor microenvironment.
  • Reliable and Accurate Results: The inclusion of internal quality controls and lyophilized standards ensures that assay performance is consistent, leading to trustworthy results.
  • User-Friendly Setup: The comprehensive kit contains everything needed for the assay, simplifying the setup process and reducing the likelihood of errors during preparation.
  • Enhanced Research Efficiency: The ability to perform multiplex analysis allows for increased throughput, enabling researchers to analyze more samples in less time, which is critical in high-volume research settings.

General description

Circulating cancer biomarkers give insight beyond intracellular oncogenesis and into how the body responds to the presence of a tumor, the dysregulation of homeostasis, and the relationship between a tumor and its environment. Multianalyte panels have become essential tools that enable researchers to measure cancer biomarkers simultaneously, teasing out these relationships and applying them to understand tumor biology.

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

Storage Class

10 - Combustible liquids

wgk

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Chen-Tzu Chiu et al.
Cancers, 12(6) (2020-06-18)
Head and neck cancer (HNC) accounts for more than 330,000 cancer deaths annually worldwide. Despite late diagnosis being a major factor contributing to HNC mortality, no satisfactory biomarkers exist for early disease detection. Cytoplasmic gelsolin (cGSN) was discovered to predict
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
Pils, D; Tong, D; Hager, G; Obermayr, E; Aust, S; Heinze, G; Kohl, M; Schuster, E; Wolf et al.
BMC Cancer null
Sandra Tuyaerts et al.
Frontiers in nutrition, 5, 138-138 (2019-01-29)
Curcumin is a botanical with anti-tumor and immunomodulatory properties. We hypothesized that curcumin supplementation might influence inflammatory biomarker levels in endometrial carcinoma (EC). In this open-label, non-randomized phase 2 study (NCT02017353), seven EC patients consumed 2 g/day Curcumin Phytosome (CP)
Jonathan A Kluge et al.
Proceedings of the National Academy of Sciences of the United States of America, 113(21), 5892-5897 (2016-05-11)
Advanced personalized medical diagnostics depend on the availability of high-quality biological samples. These are typically biofluids, such as blood, saliva, or urine; and their collection and storage is critical to obtain reliable results. Without proper temperature regulation, protein biomarkers in
Effect of different exercise modalities plus a hypocaloric diet on inflammation markers in overweight patients: a randomised trial.
Loria-Kohen, V; Fernandez-Fernandez, C; Bermejo, LM; Morencos, E; Romero-Moraleda et al.
Clinical Nutrition (Edinburgh, Scotland) null

Global Trade Item Number

SKUGTIN
HCCBP1MAG-58K-1804053252803192
HCCBP1MAG-58K-2204053252803239
HCCBP1MAG-58K-0404053252803062
HCCBP1MAG-58K-2404053252803253
HCCBP1MAG-58K-0804053252794025
HCCBP1MAG-58K-1004053252803116
HCCBP1MAG-58K-1104053252803123
HCCBP1MAG-58K-1504053252803161
HCCBP1MAG-58K-1604053252803178
HCCBP1MAG-58K-1704053252803185
HCCBP1MAG-58K-1904053252803208
HCCBP1MAG-58K-2004053252803215
HCCBP1MAG-58K-0104053252803031
HCCBP1MAG-58K-2104053252803222
HCCBP1MAG-58K-0204053252803048
HCCBP1MAG-58K-0504053252803079
HCCBP1MAG-58K-0704053252803093
HCCBP1MAG-58K-0304053252803055
HCCBP1MAG-58K-2304053252803246
HCCBP1MAG-58K-0604053252803086
HCCBP1MAG-58K-0904053252803109
HCCBP1MAG-58K-1204053252803130
HCCBP1MAG-58K-1304053252803147
HCCBP1MAG-58K-1404053252803154

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service